Turn recording back on
A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT).
Sunkara SK, Coomarasamy A, Khalaf Y, Braude P.
Reprod Health. 2007 Dec 28;4:12.
PMID: 18163902 [PubMed - in process]
Related Articles Free article in PMC
Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis.
Sunkara SK, Tuthill J, Khairy M, El-Toukhy T, Coomarasamy A, Khalaf Y, Braude P.
Reprod Biomed Online. 2007 Nov;15(5):539-46. Review.
PMID: 18028745 [PubMed - indexed for MEDLINE]
Related Articles
Interventions for 'poor responders' to controlled ovarian hyperstimulation (COH) in in-vitro fertilisation (IVF).
Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, McTavish AR.
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD004379. Review.
PMID: 17253503 [PubMed - indexed for MEDLINE]
A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
Hohmann FP, Macklon NS, Fauser BC.
J Clin Endocrinol Metab. 2003 Jan;88(1):166-73.
PMID: 12519847 [PubMed - indexed for MEDLINE]
A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization.
Barmat LI, Chantilis SJ, Hurst BS, Dickey RP.
Fertil Steril. 2005 Feb;83(2):321-30.
PMID: 15705369 [PubMed - indexed for MEDLINE]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.
Health Technol Assess. 2001;5(28):1-110. Review.
PMID: 11701100 [PubMed - indexed for MEDLINE]
Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE, Saconato H, Maciel MC.
Cochrane Database Syst Rev. 2005 Jan 25;(1):CD002808. Review.
PMID: 15674898 [PubMed - indexed for MEDLINE]
GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial.
Cheung LP, Lam PM, Lok IH, Chiu TT, Yeung SY, Tjer CC, Haines CJ.
Hum Reprod. 2005 Mar;20(3):616-21. Epub 2004 Dec 17.
PMID: 15608037 [PubMed - indexed for MEDLINE]
Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
Surrey ES, Bower J, Hill DM, Ramsey J, Surrey MW.
Fertil Steril. 1998 Mar;69(3):419-24.
PMID: 9531870 [PubMed - indexed for MEDLINE]
[Protocol of GNRH antagonist in poor responders in IVF-ET cycles]
Grzechocińska B, Fracki S, Marianowski P, Dworniak T, Bablok L, Marianowski L.
Ginekol Pol. 2003 Sep;74(9):943-8. Polish.
PMID: 14674149 [PubMed - indexed for MEDLINE]
In vitro fertilisation for unexplained subfertility.
Pandian Z, Bhattacharya S, Vale L, Templeton A.
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003357. Review.
PMID: 15846658 [PubMed - indexed for MEDLINE]
Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization.
Dirnfeld M, Fruchter O, Yshai D, Lissak A, Ahdut A, Abramovici H.
Fertil Steril. 1999 Sep;72(3):406-11.
PMID: 10519608 [PubMed - indexed for MEDLINE]
Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z.
Hum Reprod. 1997 Nov;12(11):2359-65.
PMID: 9436663 [PubMed - indexed for MEDLINE]
A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS.
Fertil Steril. 2006 Jul;86(1):58-63. Epub 2006 Jun 6.
PMID: 16753156 [PubMed - indexed for MEDLINE]
A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients.
Rombauts L, Healy D, Norman RJ; Orgalutran Scheduling Study Group.
Hum Reprod. 2006 Jan;21(1):95-103. Epub 2005 Oct 27. Erratum in: Hum Reprod. 2006 Nov;21(11):3032.
PMID: 16253978 [PubMed - indexed for MEDLINE]
Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles.
Mochtar MH, Van der Veen, Ziech M, van Wely M.
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005070. Review.
PMID: 17443569 [PubMed - indexed for MEDLINE]
A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK, Das T, Chattopadhyay R, Sawhney V, Kumar J, Chaudhury K, Chakravarty BN, Kabir SN.
Hum Reprod. 2004 Sep;19(9):2031-5. Epub 2004 Jun 24.
PMID: 15217999 [PubMed - indexed for MEDLINE]
Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.
Borm G, Mannaerts B.
Hum Reprod. 2000 Jul;15(7):1490-8. Erratum in: Hum Reprod 2000 Aug;15(8):1877.
PMID: 10875855 [PubMed - indexed for MEDLINE]
A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, Aragona C.
Fertil Steril. 2004 Jun;81(6):1542-7.
PMID: 15193474 [PubMed - indexed for MEDLINE]
LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.
Peñarrubia J, Fábregues F, Creus M, Manau D, Casamitjana R, Guimerá M, Carmona F, Vanrell JA, Balasch J.
Hum Reprod. 2003 Dec;18(12):2689-97.
PMID: 14645193 [PubMed - indexed for MEDLINE]